To study the survival outcomes of uncommon recurrences among patients with cervical cancer compared with loco-regional and nodal recurrences at a tertiary care center in North East India – Bridging the knowledge gap in the existing literature.

IF 1.5 Q3 OBSTETRICS & GYNECOLOGY
Mahendra Kumar , Upasana Baruah , Dimpy Begum , Debabrata Barmon , Jyotiman Nath , Duncan Khanikar , Karthik Chandra Bassetty
{"title":"To study the survival outcomes of uncommon recurrences among patients with cervical cancer compared with loco-regional and nodal recurrences at a tertiary care center in North East India – Bridging the knowledge gap in the existing literature.","authors":"Mahendra Kumar ,&nbsp;Upasana Baruah ,&nbsp;Dimpy Begum ,&nbsp;Debabrata Barmon ,&nbsp;Jyotiman Nath ,&nbsp;Duncan Khanikar ,&nbsp;Karthik Chandra Bassetty","doi":"10.1016/j.eurox.2024.100314","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Recurrence rates of FIGO stage IB-IIA and IIB-IVA cervical cancer <!--> <!-->28–64<!--> <!--> respectively. There is a scarcity of data on the recurrence recurrence pattern for unusual sites and theirrecurrence pattern for unusual sites and its association with survival and prognosis.</p></div><div><h3>Objective</h3><p>To study overall survival in patients with distant metastasis compared to local and regional nodal metastasis.</p></div><div><h3>Methods</h3><p>A retrospective study was done from 1/1/2017 to 30/12/22. Cervical cancer patients post primary treatments were included. Survival was analyzed with respect to 3 groups local, regional nodalconducted from 1/1/2017 to 30/12/22. Cervical cancer patients who had received primary post-primary treatments were included. Survival was analyzed with respect to three groups: local, regional nodal, and distant metastasis.</p></div><div><h3>Results</h3><p>225 patients had recurrences <!--> <!--> <!-->post-completion of primary treatment, of which 105 (46.6%)(46.6 %) had local, 46 (20.4%)(20.4 %) had regional nodal, and 74 (33.3<!--> <!-->%) had distant recurrences. The median time for recurrence in local, regional nodal, and atypical recurrences were 9, 9, and 13 months (p value - &lt;0.05), respectively. Treatment included systemic chemotherapy 122 (54.2<!--> <!-->%), metronomic therapy 19 (8.4<!--> <!-->%), palliative radiotherapy 44 (19.5<!--> <!-->%), palliative surgery 8 (3.5<!--> <!-->%) and best supportive care 30 (13.3<!--> <!-->%) patients. Median Time to treatment-death of patients after recurrence in local, nodal and distant recurrences was 17.0 months, 18.0 months and 10.0 months respectively (p value - &lt; 0.05). Overall Survival of patients after primary treatment with local, nodal and distant recurrences was 35.0 months, 47.0 months and 50.0 months respectively (p value &lt;0.05).</p></div><div><h3>Conclusion</h3><p>Local recurrence is most common, followed by regional, nodal, and distant recurrences. Overall survival post recurrence was lowest for distant recurrences and highest for local recurrences however overall survival after primary treatment completion was highest for distant recurrence due to the late presen; however, tation of distant recurrences.</p></div>","PeriodicalId":37085,"journal":{"name":"European Journal of Obstetrics and Gynecology and Reproductive Biology: X","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590161324000346/pdfft?md5=7878f7ff63892c9147810c04da00cf16&pid=1-s2.0-S2590161324000346-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Obstetrics and Gynecology and Reproductive Biology: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590161324000346","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Recurrence rates of FIGO stage IB-IIA and IIB-IVA cervical cancer  28–64  respectively. There is a scarcity of data on the recurrence recurrence pattern for unusual sites and theirrecurrence pattern for unusual sites and its association with survival and prognosis.

Objective

To study overall survival in patients with distant metastasis compared to local and regional nodal metastasis.

Methods

A retrospective study was done from 1/1/2017 to 30/12/22. Cervical cancer patients post primary treatments were included. Survival was analyzed with respect to 3 groups local, regional nodalconducted from 1/1/2017 to 30/12/22. Cervical cancer patients who had received primary post-primary treatments were included. Survival was analyzed with respect to three groups: local, regional nodal, and distant metastasis.

Results

225 patients had recurrences   post-completion of primary treatment, of which 105 (46.6%)(46.6 %) had local, 46 (20.4%)(20.4 %) had regional nodal, and 74 (33.3 %) had distant recurrences. The median time for recurrence in local, regional nodal, and atypical recurrences were 9, 9, and 13 months (p value - <0.05), respectively. Treatment included systemic chemotherapy 122 (54.2 %), metronomic therapy 19 (8.4 %), palliative radiotherapy 44 (19.5 %), palliative surgery 8 (3.5 %) and best supportive care 30 (13.3 %) patients. Median Time to treatment-death of patients after recurrence in local, nodal and distant recurrences was 17.0 months, 18.0 months and 10.0 months respectively (p value - < 0.05). Overall Survival of patients after primary treatment with local, nodal and distant recurrences was 35.0 months, 47.0 months and 50.0 months respectively (p value <0.05).

Conclusion

Local recurrence is most common, followed by regional, nodal, and distant recurrences. Overall survival post recurrence was lowest for distant recurrences and highest for local recurrences however overall survival after primary treatment completion was highest for distant recurrence due to the late presen; however, tation of distant recurrences.

在印度东北部的一家三级医疗中心研究宫颈癌患者非常见复发与局部区域性复发和结节性复发的生存结果对比--弥补现有文献中的知识空白。
背景FIGO IB-IIA期和IIB-IVA期宫颈癌的复发率分别为28%-64%。关于异常部位复发的复发模式、异常部位复发的复发模式及其与生存率和预后的关系的数据非常稀少。研究对象包括接受初治后的宫颈癌患者。从 2017 年 1 月 1 日至 2012 年 12 月 30 日,对 3 组局部、区域结节转移患者的生存率进行了分析。包括接受初治后的宫颈癌患者。结果225例患者在完成初治后复发,其中105例(46.6%)(46.6%)为局部复发,46例(20.4%)(20.4%)为区域结节复发,74例(33.3%)为远处复发。局部、区域结节和非典型复发的中位复发时间分别为 9 个月、9 个月和 13 个月(P 值 - <0.05)。治疗方法包括全身化疗 122 例(54.2%)、节律疗法 19 例(8.4%)、姑息放疗 44 例(19.5%)、姑息手术 8 例(3.5%)和最佳支持治疗 30 例(13.3%)。局部复发、结节复发和远处复发患者治疗后死亡的中位时间分别为 17.0 个月、18.0 个月和 10.0 个月(P 值 - <0.05)。结论局部复发最常见,其次是区域、结节和远处复发。远处复发后的总生存期最低,局部复发后的总生存期最高,但由于远处复发出现较晚,因此远处复发后的总生存期最高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.20
自引率
0.00%
发文量
31
审稿时长
58 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信